TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT03649464

Investigation of Oral OKN-007 in Recurrent High-grade Glioma Participants

Cause of deathOther Automatic label, confidence 0.5, unverified. How labels are made.
“Planned to execute the new Oral OKN-007 clinical trial with modified study plan soon. This Study not proceeding and sites never opened.”

The sponsor’s own words in the registry.

Life of this trial

201820192020202120222023Registered2018-08-17Planned start2022-08 (planned)Withdrawn (as of)2022-10-07

Vital statistics

Status
Withdrawn
Phase
Phase 1, Phase 2
Sponsor
Oblato, Inc.
Sponsor type
Industry
Conditions
Glioblastoma; Astrocytoma; Oligodendroglioma
Interventions
OKN-007
Participants
0

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.